Association of the tumor necrosis factor-alpha -308G>A polymorphism with breast cancer in Mexican women

Genetics and Molecular Research

Volumn 12, Issue 4, 2013, Pages 5680-5693

  Gomez Flores Ramos L ^a,b   Escoto De Dios, A ^a   Puebla Perez A M ^b   Figuera Villanueva, L E ^a   Ramos Silva, A ^a,b   Ramirez Patino R ^a,b   Delgado Saucedo, J I ^b   Salas Gonzalez E ^a   Zuniga Gonzalez G M ^a   Alonzo Rojo, A ^a,b   Gutierrez Hurtado I ^a,b   Gallegos Arreola, M P ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

308G>A; Breast cancer; Mexican population; Obesity; Risk factor; Tumor necrosis factor alpha

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIRUBICIN; FLUOROURACIL; KI 67 ANTIGEN; PACLITAXEL; TRASTUZUMAB; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; BREAST METASTASIS; CANCER STAGING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DRUG RESPONSE; FEMALE; GENE FREQUENCY; GENOTYPE; HEMATOCRIT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MEXICO; MIDDLE AGED; OBESITY; PREMENOPAUSE; TUMOR NECROSIS FACTOR ALPHA GENE; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MEXICO; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888102035     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2013.November.18.17     Document Type: Article

References (40)

1. Abdulrahman GO Jr. and Rahman GA (2012). Epidemiology of breast cancer in europe and Africa. J. Cancer Epidemiol. 2012: 915610.
2. Alokail MS, Al-Daghri NM, Al-Attas OS and Hussain T (2009). Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women. Cardiovasc. Diabetol. 8: 33.
3. Anonymous (2013). rs361525. Available at [http://www.ncbi.nlm.nih.gov/SNP/sn.cgi?rs=361525]. Accessed October 20, 2012.
4. Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, et al. (2004). Role of tumour necrosis factor gene polymorphisms (-308 and-238) in breast cancer susceptibility and severity. Breast Cancer Res. 6: R395-R400.
5. Bandi MS, Brinton L, Buchert S and Cokkinides V (2010). Breast cancer facts and figures 2009-2010. Available at [http://www.cancer.org/acs/groups/content/@nho/documents/document/f861009final90809pdf.pdf]. American Cancer Society. Accessed October 22, 2012.
6. Berberoglu U, Yildirim E and Celen O (2004). Serum levels of tumor necrosis factor alpha correlate with response to neoadjuvant chemotherapy in locally advanced breast cancer. Int. J. Biol. Markers 19: 130-134.
7. Braun S, Bitton-Worms K and LeRoith D (2011). The link between the metabolic syndrome and cancer. Int. J. Biol. Sci. 7: 1003-1015.
8. Cereda C, Gagliardi S, Cova E, Diamanti L, et al (2012). The Role of TNF-Alpha in ALS: New Hypotheses for Future Therapeutic Approaches, Amyotrophic Lateral Sclerosis. InTech (Martin H. Maurer, ed.). Available from [http://www.intechopen.com/books/amyotrophic-lateral-sclerosis/the-role-of-tnf-alpha-in-als-new-hypotheses-for-future-therapeutic-approaches] Accessed October 22, 2012.
9. Champ CE, Volek JS, Siglin J, Jin L, et al. (2012). Weight gain, metabolic syndrome, and breast cancer recurrence: are dietary recommendations supported by the data. Int. J. Breast Cancer 2012: 506868.
10. Chu H, Yang J, Mi S, Bhuyan SS, et al. (2012). Tumor necrosis factor-alpha G-308 A polymorphism and risk of coronary heart disease and myocardial infarction: A case-control study and meta-analysis. J. Cardiovasc. Dis. Res 3: 84-90.
11. Duggan C, Irwin ML, Xiao L, Henderson KD, et al. (2011). Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J. Clin. Oncol. 29: 32-39.
12. Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, Thompson A, et al. (2011). Diabetes mellitus, fasting glucose, and risk of cause-specific death. N. Engl. J. Med. 364: 829-841.
13. Fang F, Yao L, Yu XJ, Yu L, et al. (2010). TNFalpha-308 G/A polymorphism is associated with breast cancer risk: a meta-analysis involving 10,184 cases and 12,911 controls. Breast Cancer Res. Treat. 122: 267-271.
14. Feng RN, Zhao C, Sun CH and Li Y (2011). Meta-analysis of TNF 308 G/A polymorphism and type 2 diabetes mellitus. PLoS One 6: e18480.
15. Fernández-Real JM, Menendez JA, Frühbeck G, Moreno-Navarrete JM, et al. (2010). Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss. Nutr. Metab. 7: 14.
16. Gallegos-Arreola MP, Valencia-Rodríguez LE, Puebla-Pérez AM, Figuera LE, et al. (2012). The TP53 16-bp duplication polymorphism is enriched in endometriosis patients. Gynecol. Obstet. Invest. 73: 118-123.
17. Gilbert CA and Slingerland JM (2013). Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu. Rev. Med. 64: 45-57.
18. Guadagni F, Ferroni P, Palmirotta R, Portarena I, et al. (2007). Review. TNF/VEGF cross-talk in chronic inflammation-related cancer initiation and progression: an early target in anticancer therapeutic strategy. In Vivo 21: 147-161.
19. Henry D, Abels R and Larholt K (1995). Prediction of response to recombinant human erythropoietin (r-HuEPO/epoetin-alpha) therapy in cancer patients. Blood 85: 1676-1678.
20. Knaul FM, Nigenda G, Lozano R, Arreola-Ornelas H, et al. (2009). Breast cancer in Mexico: an urgent priority. Salud Publica Mex. 51 (Suppl 2): s335-s344.
21. Lazcano-Ponce EC, Iovar-Guzmán V, Alonso-de Ruiz P and López-Carrielo L (1996). Breast cancer. A historical theme, present and future. J. Public Health 38: 139-152.
22. Li FN, Zhang DL, Li YD and Jiang GM (2008). Association of cytokine gene polymorphisms with cachexia related to sporadic female breast cancer. Zhonghua Yi Xue Za Zhi. 88: 1402-1404.
23. Lorincz AM and Sukumar S (2006). Molecular links between obesity and breast cancer. Endocr. Relat. Cancer 13: 279-292.
24. Lyu MA and Rosenblum MG (2005). The immunocytokine scFv23/TNF sensitizes HER-2/neu-overexpressing SKBR-3 cells to tumor necrosis factor (TNF) via up-regulation of TNF receptor-1. Mol. Cancer Ther. 4: 1205-1213.
25. Maccio A and Madeddu C (2011). Obesity, inflammation, and postmenopausal breast cancer: therapeutic implications. Scientific World J. 11: 2020-2036.
26. Mihlon F 4th, Ray CE Jr and Messersmith W (2010). Chemotherapy agents: a primer for the interventional radiologist. Semin. Intervent. Radiol. 27: 384-390.
27. Miller JW, King JB, Joseph DA and Richardson LC (2012). Breast cancer screening among adult women--Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb. Mortal. Wkly. Rep. 61 Suppl: 46-50.
28. Miller SA, Dykes DD and Polesky HF (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
29. Orosz P, Echtenacher B, Falk W, Rüschoff J, et al. (1993). Enhancement of experimental metastasis by tumor necrosis factor. J. Exp. Med. 177: 1391-1398.
30. Parkin DM (2011). Cancers attributable to reproductive factors in the UK in 2010. Br. J. Cancer 105 (Suppl 2): S73-S76.
31. Parra-Rojas I, Ruíz-Madrigal B, Martínez-López E and Panduro A (2006). Influence of the-308 TNF-alpha and-174 IL-6 polymorphisms on lipid profile in Mexican subjects. Hereditas 143: 167-172.
32. Perks CM and Holly JM (2011). Hormonal mechanisms underlying the relationship between obesity and breast cancer. Endocrinol. Metab. Clin. North Am. 40: 485-507.
33. Pooja S, Francis A, Bid HK, Kumar S, et al. (2011). Role of ethnic variations in TNF-α and TNF-β polymorphisms and risk of breast cancer in India. Breast Cancer Res. Treat. 126: 739-747.
34. Sanchez-Domínguez CN, Buenfil-Lozano JA, Molina-Guajardo CA, Borjas-Almaguer OD, et al. (2008). Frequency of S and Z alleles for alpha-1-antitrypsin and tumor necrosis factor alpha-308 promoter polymorphism in northeastern Mexico. Allergy Asthma Proc. 29: 406-410.
35. Sanguinetti CJ, Dias NE and Simpson AJ (1994). Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 17: 914-921.
36. Shen C, Sun H, Sun D, Xu L, et al. (2011). Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysis. Breast Cancer Res. Treat. 126: 763-770.
37. Anonymous (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363: 157-163.
38. Wilson AG, di Giovine FS, Blakemore AI and Duff GW (1992). Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum. Mol. Genet. 1: 353.
39. Yang Y, Feng R, Bi S and Xu Y (2011). TNF-alpha polymorphisms and breast cancer. Breast Cancer Res. Treat. 129: 513-519.
40. Zhou BP, Hu MC, Miller SA, Yu Z, et al. (2000). HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway. J. Biol. Chem. 275: 8027-8031.